Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intracranial Atherosclerosis Screen Based on Retinal Imaging Characteristic

NCT06610578 is registered in ClinicalTrials.gov with Xuanwu Hospital, Beijing as lead sponsor.

NCT NCT06610578
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06610578 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intracranial Atherosclerosis Screen Based on Retinal Imaging Characteristic
Lead sponsor
Xuanwu Hospital, Beijing
Phase
Observational
Overall status
Recruiting
Start date
September 5, 2024
Completion date
September 30, 2027
Enrollment
2,100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intracranial atherosclerosis